A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to determine whether nivolumab monotherapy or in combination with Standard of care (SOC) therapies will provide clinical benefit (i.e., PFS, OS, and DOR) without unacceptable toxicity in advanced Non-Small Cell Lung Cancer patients.
Epistemonikos ID: b4f5f3f430e8cd4cb8166a271ad8b72b741ac7c6
First added on: May 12, 2024